Entry Detail



General Information

Database ID:exR0760916
RNA Name:MTRNR2L1
RNA Type:mRNA
Chromosome:chr17
Starnd:+
Coordinate:
Start Site(bp):22523111End Site(bp):22524663
External Links:ENSG00000256618



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE106804
Description:Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:13
Number of Control:6
Number of Samples:19





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ACIN1
chr14
23058564
23095614
-
AK2
chr1
33007940
33080996
-
ACACA
chr17
37084992
37406836
-
AC006978.2
chr7
30362400
30412502
+
AC020909.1
chr19
50415799
50428409
+
AC004922.1
chr7
99325879
99394653
+
ACTG1
chr17
81509971
81523847
-
AC015813.2
chr17
57989038
58007246
-
AC009133.6
chr16
29812261
29820092
+
AC087289.3
chr17
75898645
75930129
-
AL035078.4
chr11
31812391
32104665
+
AK4
chr1
65147549
65232145
+
AL360181.3
chr10
133380017
133420271
+
ACLY
chr17
41866917
41930542
-
ACTG2
chr2
73892314
73919865
+
AC116366.3
chr5
132410832
132646079
+
AC139530.2
chr17
81703371
81720539
+
ABI1
chr10
26746593
26861087
-
ACSL4
chrX
109624244
109733403
-
AKT1
chr14
104769349
104795751
-
AC008750.8
chr19
51350373
51368099
-
ACBD6
chr1
180269653
180502954
-
AC073508.2
chr17
40627356
40665141
-
AC120057.2
chr17
7240427
7244635
-
AGMAT
chr1
15571699
15585051
-
AC134669.1
chr17
31305213
31318831
-
ADAM17
chr2
9488486
9556732
-
ABL1
chr9
130713016
130887675
+
ACTB
chr7
5527148
5563784
-
AC068946.2
chr2
219209772
219222738
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-632
chr17
32350169
32350187
+
hsa-miR-4315
chr17
45475408
45475425
-
hsa-miR-4485-3p
chr11
10508277
10508296
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004687.1
chr17
58330884
58332508
-
AC007780.1
chr17
68413623
68524949
+
AC007952.4
chr17
19112000
19112636
-
AC009831.1
chr18
31942575
31944156
+
AC016831.1
chr7
130876809
130913310
-
AC016876.2
chr17
7581964
7584086
-
AC021078.1
chr5
149494314
149504670
-
AC060780.1
chr17
43148368
43171037
-
AC067930.1
chr8
143579636
143580670
+
AC079781.5
chr7
97851688
97972985
-
AC092620.2
chr2
138599663
138602426
-
AC098850.4
chr17
16788057
16816540
+
AC104461.1
chr1
200333193
200478669
+
AC113189.4
chr17
7439506
7445966
+
AC126365.1
chr17
20788071
20789584
+
AC129492.1
chr17
8079482
8081565
+
AC245014.3
chr1
145281116
145281462
+
AD000090.1
chr19
35557956
35581954
+
ADIRF-AS1
chr10
86965345
86971311
-
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:29330365
Title:Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
Author:Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL.
Journal:Nat Commun. 2018 Jan 12;9(1):175.
Description:Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.